Replies to post #215750 on Biotech Values

[DewDiligence]

Dysport has annualized worldwide sales of roughly $500M. Sales reported by Ipsen were €$164M ($194M) in 1H17 and were €77M ($91M) in 3Q17 (a seasonally slow period); Ipsen’s reported figures include amounts sold by Galderma in North America, but not amounts sold by Galderma in the rest of world:

https://www.ipsen.com/websites/IPSENCOM-PROD/wp-content/uploads/2017/07/28144841/Ipsen-Half-Year-2017-Financial-Results.pdf
https://www.ipsen.com/media/press-relase/ipsen-delivers-strong-sales-growth-22-6-third-quarter-2017-confirms-full-year-guidance/